Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis

被引：0
|
作者：
Juan J. Rodriguez
Luis E. Baron
Oscar C. Munoz
Jonathan J. Diaz
机构：
[1] Texas Tech University Health Sciences Center,Facultad de Medicina
[2] Universidad Autonoma de Bucaramanga,Facultad de Medicina
[3] Universidad de Boyaca,undefined
来源：
Current Cardiology Reports | 2022年 / 24卷
关键词：
Monotherapy; Antiplatelet therapy; Atherosclerosic disease; Stroke; Myocardial infarction; Peripheral arterial disease; Secondary prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 91
页数：4
相关论文
共 50 条
  • [31] CLINICAL OUTCOMES OF P2Y12 INHIBITOR MONOTHERAPY IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: LESS IS MORE!
    Ibrahim, Homam
    Staniloae, Cesar
    Fuentes, Jorge
    Gonzalez-Lengua, Carlos
    Vidal, Samantha
    Gaudio, Stephanie
    Tovar, Joseph
    Jilaihawi, Hasan
    Querijero, Michael
    Neuburger, Peter
    Williams, Mathew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1173 - 1173
  • [32] P2Y12 INHIBITOR MONOTHERAPY VERSUS CONVENTIONAL DUAL ANTIPLATELET THERAPY OR ASPIRIN MONOTHERAPY IN ACUTE CORONARY SYNDROME
    Song, P. -S.
    ATHEROSCLEROSIS, 2021, 331 : E266 - E266
  • [33] P2Y12 Inhibitor Monotherapy Is Superior to Aspirin Monotherapy in Chronic Limb-Threatening Ischemia Postendovascular Intervention
    Fakhoury, Elias
    Khan, Sikandar
    O'Brien-Irr, Monica
    Dosluoglu, Hasan H.
    Harris, Linda
    Rivero, Mariel
    Cherr, Gregory
    Dryjski, Maciej
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : E248 - E248
  • [34] P2Y12 Inhibitor Monotherapy Versus Aspirin Monotherapy After 12 Months of DAPT in Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis
    Rahman, Hammad Ur
    Khan, Muhammad Aslam
    Lone, Ahmad
    Ghosh, Priyanka
    Hammad, Tehseen
    Sattur, Sudhakar
    Kaluski, Edo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (04) : S15 - S15
  • [35] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
  • [36] Role of P2Y12 Receptor in Thrombosis
    Zhang, Yaqi
    Zhang, Si
    Ding, Zhongren
    THROMBOSIS AND EMBOLISM: FROM RESEARCH TO CLINICAL PRACTICE, VOL 1, 2017, 906 : 307 - 324
  • [37] Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor
    Beavers, Craig J.
    Effoe, Samuel. Aaron
    Dobesh, Paul P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 161 - 167
  • [38] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [39] Potent P2Y12 Inhibitor Therapy for All?
    Brown, Oliver I.
    Rossington, Jennifer A.
    Hoye, Angela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (11) : 1425 - 1425
  • [40] Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?
    Chandiramani, Rishi
    Mehta, Adhya
    Blumenthal, Roger S.
    Williams, Marlene S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (11) : 649 - 658
12345